TFAP2B and obesity disorder: No heterogeneity between the study groups was observed for the investigated variants, except for TFAP2B rs987237 in the combined QT analysis in relation to general obesity (BMI) (Fixed effect, I2: 78%[41%–92%], p = 0.003) (Table S4).